Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Gestational Hypertension
- Hypertension Pregnancy-induced
- Postpartum Preeclampsia
- Postpartum Pregnancy-Induced Hypertension
- Pre Eclampsia
- Superimposed Pre-Eclampsia
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: double-blind randomized placebo controlled clinical trialMasking: Triple (Participant, Care Provider, Investigator)Masking Description: Randomization will be performed by a person not involved in the clinical trial using a computer random list of numbers generated using STATA (StataCorp 14.0, Dallas, TX). This list of random number assignments will be kept secure and sent directly to the investigational drug service (IDS), who will be responsible for the allocation and dispensing of the medicationsPrimary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 50 years
- Gender
- Only males
Description
To evaluate effectiveness of hydrochlorothiazide prophylaxis on prophylaxis, prevention and relapse of preeclampsia or gestational hypertension on readmission rates, need for additional antihypertensive therapy and number of triage visits.
To evaluate effectiveness of hydrochlorothiazide prophylaxis on prophylaxis, prevention and relapse of preeclampsia or gestational hypertension on readmission rates, need for additional antihypertensive therapy and number of triage visits.
Tracking Information
- NCT #
- NCT03298802
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Antonio Saad, M.D. UTMB
Get Well Soon